Klinikum der Universität München - Medizinische Klinik V
- Address
- lock Available on a paid plan
Klinikum der Universität München - Medizinische Klinik V
The Medizinische Klinik V at Klinikum der Universität München is a specialized clinical research center focused on gastrointestinal and metabolic disorders. The center demonstrates particular expertise in managing complex conditions requiring advanced therapeutic interventions and patient-centered treatment approaches.
- Cystic fibrosis management and complications
- Pancreatic exocrine insufficiency treatment optimization
- Enzyme replacement therapy evaluation
The center actively participates in innovative clinical trials evaluating novel formulations and therapeutic strategies for patients with cystic fibrosis and associated pancreatic exocrine insufficiency. Through multicenter collaborative studies, the clinic assesses patient acceptability and clinical efficacy of gastro-resistant enzyme preparations, contributing to improved quality of life and therapeutic outcomes for this challenging patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinikum der Universität München - Medizinische Klinik V
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Patient Acceptability of a New Pancreas Powder Formulation in Cystic Fibrosis Patients with Pancreatic Exocrine Insufficiency | MEDA Pharma GmbH & Co. KG | Phase I | Not Recruiting | Apr 2024 | Dec 2024 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pancreas Powder | 1 | Unknown | 2024-04-18 | 2024-04-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.